K. Kerlin

Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer

William U. Shipley, Wendy Seiferheld, Himanshu Lukka et al. · New England Journal of Medicine · 2017 · 662 citations · Full text

Medicine, Oncology, Urology +16

RTOG 9804: A Prospective Randomized Trial for Good-Risk Ductal Carcinoma In Situ Comparing Radiotherapy With Observation

Beryl McCormick, Kathryn Winter, Clifford A. Hudis et al. · Journal of Clinical Oncology · 2015 · 395 citations · Full text

Medicine, Oncology, Radiation Oncology +17

A Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group Phase 3 Randomized Trial NRG Oncology RTOG 9902

Seth A. Rosenthal, Daniel Hunt, Oliver Sartor et al. · International Journal of Radiation Oncology*Biology*Physics · 2015 · 78 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Phase III Multi-Institutional Trial of Adjuvant Chemotherapy With Paclitaxel, Estramustine, and Oral Etoposide Combined With Long-Term Androgen Suppression Therapy and Radiotherapy Versus Long-Term Androgen Suppression Plus Radiotherapy Alone for High-Risk Prostate Cancer: Preliminary Toxicity Analysis of RTOG 99-02

Seth A. Rosenthal, Kyoungwha Bae, Kenneth J. Pienta et al. · International Journal of Radiation Oncology*Biology*Physics · 2008 · 66 citations

Medicine, Oncology, Radiation Oncology +16

Report of NRG Oncology/RTOG 9601, A Phase 3 Trial in Prostate Cancer: Anti-androgen Therapy (AAT) With Bicalutamide During and After Radiation Therapy (RT) in Patients Following Radical Prostatectomy (RP) With pT2-3pN0 Disease and an Elevated PSA

William U. Shipley, Wendy Seiferheld, Himu Lukka et al. · International Journal of Radiation Oncology*Biology*Physics · 2015 · 23 citations

Medicine, Oncology, Urology +17